| Literature DB >> 24146936 |
Aurélie Gaudin1, Caroline Farnoux, Arnaud Bonnard, Marianne Alison, Laure Maury, Valérie Biran, Olivier Baud.
Abstract
Necrotizing enterocolitis (NEC) is a severe complication frequently seen during the neonatal period associated with high mortality rate and severe and prolonged morbidity including Post-NEC intestinal stricture. The aim of this study is to define the incidence and risk factors of these post-NEC strictures, in order to better orient their medicosurgical care. Sixty cases of NEC were retrospectively reviewed from a single tertiary center with identical treatment protocols throughout the period under study, including systematic X-ray contrast study. This study reports a high rate of post-NEC intestinal stricture (n = 27/48; 57% of survivors), either in cases treated surgically (91%) and after the medical treatment of NEC (47%). A colonic localization of the strictures was more frequent in medically-treated patients than in those with NEC treated surgically (87% vs. 50%). The length of the strictures was significantly shorter in case of NEC treated medically. No deaths were attributable to the presence of post-NEC stricture. The mean hospitalization time in NICU and the median age at discontinuation of parenteral nutrition were longer in the group with stricture, but this difference was not significant. The median age at discharge was significantly higher in the group with stricture (p = 0.02). The occurrence of post-NEC stricture was significantly associated with the presence of parietal signs of inflammation and thrombopenia (<100 000 platelets/mm(3)). The mean maximum CRP concentration during acute phase was significantly higher in infants who developed stricture (p<0.001), as was the mean duration of the elevation of CRP levels (p<0.001). The negative predictive value of CRP levels continually <10 mg/dL for the appearance of stricture was 100% in our study. In conclusion, this retrospective and monocentric study demonstrates the correlation between the intensity of the inflammatory syndrome and the risk of secondary intestinal stricture, when systematic contrast study is performed following NEC.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24146936 PMCID: PMC3795640 DOI: 10.1371/journal.pone.0076858
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Staging and distribution of NEC (according to Bell, modified by Walsh).
| % | (n) | |
| Grade 2a | 46 | (28) |
| Grade 2b | 12 | (7) |
| Grade 3a | 20 | (12) |
| Grade 3b | 22 | (13) |
Clinical, biological and radiological description of NEC.
| n (%) | |
| Rectorrhagia | 38 (63) |
| Respiratory and hemodynamic instability | 27 (45) |
| Metabolic acidosis | 15 (25) |
| Disseminated intravascular coagulopathy | 12 (20) |
| Thrombopenia | 15 (29) |
| Neutropenia | 20 (38) |
| CRP always <10 mg/L | 8 (15) |
| Portal venous gas | 20 (33) |
| Pneumoperitoneum | 6 (10) |
| Pathogenic agent | 18 (30) |
| Positive blood culture n = 12 | |
| Virology of stools (Adeno/Rotavirus) n = 3 |
8 cases of fulminant NEC for which data are not available were excluded.
Figure 1Evolution of NEC in the studied population.
Macroscopic characteristics of strictures.
| Medically-treatedNEC | Surgically-treated NEC | |
| 18 patients – 30 strictures | 10 patients – 16 strictures | |
| Localization | Colon: 26 (87%) | Terminal ileum: 8 (50%) |
|
| ||
| 1 | 17 (56%) | 11 (70%) |
| 2 | 8 (27%) | 2 (10%) |
| 3 | 5 (17%) | 3 (20%) |
|
| ||
| Short <2 cm | 25 (83%) | 9 (56%) |
| Long ≥5 cm | 1 (3%) | 7 (44%) |
statistically significant differences between the two groups of NEC (p<0.01).
Figure 2Treatment of strictures after contrast study (NEC cases treated medically during the acute phase).
Comparative table of groups with and without stricture.
| Stricture +(n = 27) | Stricture −(n = 21) | p-value | |
| Gestational age at birth, mean (weeks) | 31+6 | 31+2 | NS |
| Mean weight at birth, g | 1693 | 1479 | NS |
| IUGR, n (%) | 3 (11) | 5 (24) | NS |
| Sex male, n (%) | 13 (48) | 8 (38) | NS |
| Postmenstrual age at NEC, mean (weeks) | 35 | 35+3 | NS |
| Mean age, days) | 21 | 29 | NS |
| Parietal signs, n (%) | 9 (33) | 1 (5) | p = 0.039* |
| Portalvenous gas, n (%) | 9 (33) | 3 (14) | NS |
| State of shock, n (%) | 6 (22) | 2 (10) | NS |
| Disseminated intravascular coagulopathy, n (%) | 3 (11) | 1 (5) | NS |
| Thrombopenia <100 000/mm3, n (%) | 11 (41) | 2 (10) | p = 0.021* |
| Surgical treatment in acute phase, n (%) | 9 (33) | 1 (5) | p = 0.039* |
| Duration of intensive care in days, n (%) | 14 (52) | 3 (14) | p = 0.016* |
| Duration of parenteral nutrition after NEC | |||
| ≥45 days – n | 22 | 3 | |
| ≥90 days – n | 8 | 2 | |
| ≥120 days – n | 7 | 0 | |
| ≥365 days – n | 3 | 0 | |
| Median age at discontinuation of PN (days) | 90 | 56 | p = 0.06 |
| Extended digestive resection, n (%) | 6 (21) | 0 | – |
| Median age at discharge, days | 95 | 83 | p = 0.02* |
| Postmenstrual age at discharge, mean (weeks) | 50+4 | 43+1 | p = 0.009* |
| Mean weight at discharge, g | 4140 | 3032 | p = 0.004* |
Figure 3Localization of post-NEC strictures.
CRP and comparison between groups with and without stricture.
| Stricture + | Stricture − | p-value | |
|
| 27 | 21 | |
| CRP mean maximum (mg/l) | 130 | 58 | p = 0.0007 |
| Mean duration of CRP >10 mg/l(days) | 16.7 | 5.9 | p<0.0001 |
| CRP <10 mg/l (n) | 0 | 8 | p = 0.01 |
|
| 18 | 20 | |
| CRP mean maximum (mg/l) | 97 | 58 | p = 0.05 |
| Mean duration of CRP >10 mg/l(days) | 12 | 5 | p = 0.009 |
| CRP <10 mg/l (n) | 0 | 8 | p = 0.036 |